Gc Biopharma Corp

This early-stage study tested a new drug called MG1113 in 15 men with severe hemophilia A or B. The drug is given as a shot under the skin to help control bleeding. The main goal was to check safety and how the body processes the drug, not to cure the condition.

This study looked at the long-term safety and effectiveness of the drug Hunterase in people with Hunter syndrome. It included 30 patients who had already completed a previous study or had been using Hunterase for at least six months. Researchers monitored lab tests, physical exam…